VCAN was determined as a relatively novel marker for PC progression and further exploration using Oncomine and the R2 Genomics Analysis and Visualization Platform, an online genomics analysis tool, suggested that VCAN expression may play an important role in PC response to chemotherapy treatment [47]. Here, VCAN is linked to pachyonychia congenita.